On December 26, 2021 Kaya Holdings, Inc. board of directors accepted the resignation of Jordi Arimany as a director of the Company effective as of September 8, 2021. Mr. Arimany’s resignation was as a result of his relocation to South Africa. On December 26, 2021, company board of directors appointed Mitchell Chupak to fill the vacancy created by the resignation of Jordi Arimany. Mitchell Chupak has resided in Israel since 1972, where since 1997, he has been the Director of Development for the Jaffa Institute.
Kaya Holdings, Inc. is a holding company. The Company is focused on wellness and mental health through operations in psychedelic treatment clinics, medical and recreational cannabis, and cannabidiol (CBD) products. The Company produces, distributes, and/or sells a full range of cannabis products including flowers, oils, vape cartridges and cannabis infused confections, baked goods and beverages through a fully integrated group of subsidiaries and companies supporting highly distinctive brands. It operates through four subsidiaries, which include Marijuana Holdings Americas, Inc. (MJAI), Kaya Brand International, Inc. (KBI)., and Fifth Dimension Therapeutics, Inc. (FDT). MJAI maintains ownership of the Companyâs Oregon-based cannabis operations. FDT provides psychedelic mind care treatments to veterans suffering from PTSD, addicts seeking to break addiction, individuals with eating disorders, and others with an array of treatment resistant mental health disorders.
KAYA HOLDINGS, INC. 
